STRL is an earnings winner spiking from 3-3.91 with a strong move in the last hour. Stock is in a downtrend, bagholders likely to be resistance. Potential buy
MVIS company just secured a 14M contract to supply components to a "Fortune 100 Company". Potential buy.
REPH, Biotech spiking on product & facility acquisition news, very low float of 860k shares. Potential short but only on perfect setup.
MELA up on some insignificant news about new designated codes, stock ran from 3.20 to 3.60 into the close on no new news. Seems a bit sketchy. Potential short only after it spikes some more as it only has a 20M market cap
CYTX Just did a $40M dilution financing. Co loves diluting shareholders, every year the no of shares outstanding increases. The last 12 months increased by 25M alone, which represents a 33% increase. Such a crappy Co, potential short.
AXN, AST, AMRN, AMPE are all biotechs that have run up a lot. Potential shorts.
No comments:
Post a Comment